|
| Status |
Public on May 26, 2020 |
| Title |
Expression data from MCF-7 cells treated with 0, 50 and 100 uM Oxyresveratrol |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
We used microarrays to detail the global programme of gene expression underlying cellularisation and identified distinct classes of up-regulated genes during this process.
|
| |
|
| Overall design |
MCF-7 cells were seeded at 2.5 x 10^5 cells/well in 6-well plates for 24 h, then they were treated with Oxyresveratrol at the concentrations of 0, 50, and 100 μM for 24 h. Total RNA of each sample was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany)
|
| |
|
| Contributor(s) |
Radapong S |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
May 25, 2020 |
| Last update date |
May 28, 2020 |
| Contact name |
Sarayut Radapong |
| E-mail(s) |
sarayutradapong@gmail.com
|
| Phone |
07378736587
|
| Organization name |
Liverpool John Moores University
|
| Street address |
2 Hatton Garden
|
| City |
Liverpool |
| ZIP/Postal code |
L3 2EZ |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
| GPL23159 |
[Clariom_S_Human] Affymetrix Clariom S Assay, Human (Includes Pico Assay) |
|
| Samples (9)
|
| GSM4567159 |
MCF-7 treated with 0 uMOXY, biological rep1(passage no. 35) |
| GSM4567160 |
MCF-7 treated with 0 uMOXY, biological rep2 (passage no. 40) |
| GSM4567161 |
MCF-7 treated with 0 uMOXY, biological rep3 (passage no. 45) |
| GSM4567162 |
MCF-7 treated with 50 uMOXY, biological rep1(passage no. 35) |
| GSM4567163 |
MCF-7 treated with 50 uMOXY, biological rep2 (passage no. 40) |
| GSM4567164 |
MCF-7 treated with 50 uMOXY, biological rep3 (passage no. 45) |
| GSM4567165 |
MCF-7 treated with 100 uMOXY, biological rep1(passage no. 35) |
| GSM4567166 |
MCF-7 treated with 100 uMOXY, biological rep2 (passage no. 40) |
| GSM4567167 |
MCF-7 treated with 100 uMOXY, biological rep3 (passage no. 45) |
|
| Relations |
| BioProject |
PRJNA634872 |
Less...
More...